Tognon, Germana
 Distribuzione geografica
Continente #
NA - Nord America 657
EU - Europa 202
AS - Asia 156
AF - Africa 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.021
Nazione #
US - Stati Uniti d'America 651
CN - Cina 71
DE - Germania 51
SG - Singapore 46
UA - Ucraina 39
IT - Italia 38
EE - Estonia 22
HK - Hong Kong 22
FI - Finlandia 18
IE - Irlanda 12
TR - Turchia 11
GB - Regno Unito 10
CA - Canada 5
FR - Francia 5
ID - Indonesia 3
BE - Belgio 2
BR - Brasile 2
MU - Mauritius 2
AU - Australia 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
EU - Europa 1
IN - India 1
KR - Corea 1
LK - Sri Lanka 1
NL - Olanda 1
PA - Panama 1
PT - Portogallo 1
SE - Svezia 1
Totale 1.021
Città #
Fairfield 91
Woodbridge 63
Chandler 61
Seattle 52
Cambridge 40
Houston 39
Singapore 37
Ashburn 36
New York 36
Jacksonville 32
Wilmington 32
Dearborn 23
Hong Kong 22
Tallinn 22
Princeton 20
Brescia 17
Helsinki 13
Dublin 12
Istanbul 11
Shanghai 10
Ann Arbor 8
Jinan 8
Beijing 7
Los Angeles 7
Nanjing 7
Shenyang 7
Changsha 5
Nanchang 5
Des Moines 4
Hangzhou 4
London 4
Nardò 4
Jakarta 3
San Diego 3
Santa Croce sull'Arno 3
Toronto 3
Brussels 2
College Station 2
Islington 2
Jiaxing 2
Kilburn 2
Kunming 2
Lanzhou 2
Leawood 2
Milan 2
Monmouth Junction 2
Romola 2
São Paulo 2
Almere Stad 1
Augusta 1
Aveiro 1
Borgo San Giacomo 1
Brno 1
Buccinasco 1
Colombo 1
Comun Nuovo 1
Espoo 1
Falkenstein 1
Guangzhou 1
Gunzenhausen 1
Hebei 1
Hefei 1
Lappeenranta 1
Melbourne 1
Monsummano Terme 1
Mumbai 1
Munich 1
Ningbo 1
Orange 1
Ottawa 1
Pozzuoli 1
Qingzhou 1
San Francisco 1
Sofia 1
Strasbourg 1
Taizhou 1
Tianjin 1
Wuhan 1
Zhengzhou 1
Totale 806
Nome #
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 169
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 150
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 140
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 115
Prognostic factors in early-stage ovarian cancer. 99
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 87
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 62
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 61
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 55
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 48
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes 32
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma 30
Totale 1.048
Categoria #
all - tutte 6.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.049


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020151 0 0 0 0 13 30 37 24 13 25 0 9
2020/2021177 1 10 0 18 0 14 17 28 12 55 14 8
2021/2022112 15 18 0 1 0 4 12 5 4 16 12 25
2022/2023159 22 13 8 12 10 29 3 15 23 3 14 7
2023/2024146 7 6 17 10 6 40 7 7 23 7 4 12
2024/2025102 1 12 2 71 16 0 0 0 0 0 0 0
Totale 1.048